Galectin Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GALT Nasdaq 2834 http://www.galectintherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galectin Therapeutics Inc

Blog Exposure - Adamas Pharma Announced Final Results from EASE LID 2 Study Evaluating GOCOVRI in Parkinson’s Disease Patients with Dyskinesia - Apr 23rd, 2018 5:30 am
Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018 - Apr 18th, 2018 6:00 am
Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis - Apr 16th, 2018 6:00 am
Today’s Research Reports on Trending Tickers: Exelixis and Galectin Therapeutics - Apr 5th, 2018 6:30 am
Galectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018 - Apr 4th, 2018 7:00 am
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference - Apr 2nd, 2018 8:20 am
These Biotech Stocks Have a Strong Green Close on Friday - Mar 29th, 2018 4:09 pm
Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update - Mar 29th, 2018 6:10 am
Galectin Therapeutics to Present at Two International Conferences in March - Mar 9th, 2018 6:30 am
Galectin Therapeutics to Present at 2nd Annual H.C. Wainwright NASH Investor Conference - Mar 8th, 2018 6:30 am
Galectin Therapeutics Announces Record Date and Annual Stockholders Meeting Date for 2018 - Mar 5th, 2018 2:00 pm
Galectin Therapeutics to Present at 30th Annual ROTH Conference - Feb 28th, 2018 2:35 pm
Recent Analysis Shows SBA Communications, AMAG Pharmaceuticals, Galectin Therapeutics, Xilinx, J.B. Hunt Transport Services, and Southern Market Influences — Renewed Outlook, Key Drivers of Growth - Feb 16th, 2018 6:00 am
Galectin Therapeutics to Present at BIO CEO & Investor Conference - Feb 6th, 2018 7:15 am
Is Galectin Therapeutics Inc’s (NASDAQ:GALT) CEO Pay Fair? - Jan 29th, 2018 3:32 am
Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs - Jan 25th, 2018 6:30 am
Today’s Research Reports on Trending Tickers: Galectin Therapeutics and Hemispherx BioPharma - Jan 9th, 2018 6:20 am
Are Options Traders Betting on a Big Move in Galectin Therapeutics (GALT) Stock? - Jan 4th, 2018 6:40 am
Galectin Therapeutics (GALT) Jumps: Stock Rises 15.1% - Dec 28th, 2017 6:56 am
Galectin Therapeutics Inc (GALT) Springs Up 18% as Illinois Businessman Pours Millions in Credit to Finance NASH Therapy Development - Dec 20th, 2017 12:12 pm